Search Existing Tissue Requests

The Knight ADRC has supported many investigators at Washington University and at other institutions over the years. We wish to avoid the situation where two investigators study the same research question to avoid duplication of effort and potential conflict. To determine if your topic has already been studied with our resources, please search our database. If you find that your topic or a related topic has been submitted, you may wish to contact the investigator to inquire about their findings to determine how you might proceed. You may wish to collaborate or modify your request to avoid overlap. The results below reflect requests made since online requests have been accepted. As such, not all fields will have data as certain information, such as aims, were not collected until recently. If an entry has been assigned an ID number (e.g. T1004), the full request has been submitted and is either approved, disapproved or in process. If an entry has no ID number, then it represents a submission that has not yet been reviewed. Search terms are applied across an entire requests application including variables not displayed below. A more specific, detailed search may yield better results depending upon your needs.


Search Terms:


Investigator: Hongyu AN

Project Title: Neuroinflammation in Cerebral Small Vessel Disease using PET/MR Imaging

Date: October 15, 2024 at 9:51 am

Request ID: T2302-A

Aim 1: Determine if S1PR1 expression increases and colocalizes with microglia and astrocytes in post-mortem brain specimens from deceased patients with underlying CSVD.

Aim 2: Determine if neuroinflammation measured by 11C-CS1P1 uptake is independently associated with CSVD structural endpoints using in vivo PET/MR imaging.

Aim 3:

Aim 4:


Investigator: Heleen Verlinden

Project Title: Comprehensive analysis of cellular responses to Alzheimer’s and comorbid pathologies

Date: September 13, 2024 at 4:54 am

Request ID: T2416

Aim 1: To identify the cellular transcriptional changes to AD pathology in the superior frontal gyrus of postmortem human brains.

Aim 2: We aim to identify the cellular transcriptional changes to amyloid plaques without tau pathology compared to amyloid-associated tau pathology. This will help to refine the mechanism resolving amyloid stress or preventing amyloid-induced tau pathology.

Aim 3: Our overall aim is to identify new medicines to preserve cognition and other brain functions, enhance resilience to disease pathology, and slow or stop the progression of neurodegenerative diseases.

Aim 4:


Investigator: Meredith Jackrel and Jennifer Heemstra

Project Title: RNA editing in ADRD

Date: September 8, 2024 at 2:09 pm

Request ID: T2415

Aim 1: Understanding the effects of protein misfolding on A-to-I RNA editing and RNA localization in ADRD.

Aim 2:

Aim 3:

Aim 4:


Investigator: Henry Houlden

Project Title: Investigating the transcriptomic and genomic profiles of rare neurodegenerative disorders

Date: August 22, 2024 at 6:08 am

Request ID: T2414

Aim 1: Generate paired long-read DNA and RNA-seq data in each case

Aim 2: RNA expression of disease gene (and repeat expansion sizes) will differ in brain regions

Aim 3: Use this genomic and transcriptomic map to re-assess the pathogenicity of variants

Aim 4: Clinical correlation of expression differences and repeat expansion sizes in brain tissue


Investigator: Marco Colonna (PI) and Naresha Saligrama (Co-I)

Project Title: Spontaneous and Induced B cell and T cell responses in Alzheimer’s Disease

Date: August 6, 2024 at 1:28 pm

Request ID: T2413

Aim 1: Aim 1 will determine repertoires of Aβ- and Tau-specific B cells derived from different lymphopoietic sites.

Aim 2: Aim 2 will determine the impact of the site of injection and adjuvants in active immunization against Aβ and Tau.

Aim 3: Aim 3 will determine T cell and B cell responses to Aβ and Tau in human AD.

Aim 4:


Investigator: Kanekiyo, Ulrich

Project Title: Lipid signature in cerebrospinal fluid predicting the risk for cognitive impairment in the elderly

Date: July 22, 2024 at 11:49 am

Request ID: T2412

Aim 1: Assess lipiomic profile in CSF using shotgun lipidomic analysis

Aim 2: Correlate lipidomic species with AD fluid biomarkers and cognitive status

Aim 3:

Aim 4:


Investigator: Holtzman

Project Title: Using CO-detection by inDEXing (CODEX) multiplexed tissue imaging to assess immune and glial cell profiles in AD brain tissue

Date: May 17, 2024 at 3:16 pm

Request ID: T2411

Aim 1: Perform pilot staining of AD and non-AD brain sections for proof-of-feasibility

Aim 2:

Aim 3:

Aim 4:


Investigator: Dr. Robert Vassar

Project Title: Molecular and cellular mechanisms of the UNC5C netrin receptor in Alzheimer’s disease pathogenesis

Date: April 23, 2024 at 4:10 pm

Request ID: T2410

Aim 1: Determine the mechanism of UNC5C T835M-mediated cell death induced by AD-associated stressors in knockin mouse and patient hiPSC neurons in vitro.

Aim 2: Determine the mechanism of UNC5C T835M-mediated cell death induced by Aβ and Tau pathologies in vivo.

Aim 3: Identify the UNC5C T835M cell death pathway proteome induced by pathogenic Aβ and Tau using unbiased proteomics.

Aim 4:


Investigator: Moses Leavens

Project Title: Investigation of misfolded Superoxide Dismutase 1 and tau in Alzheimer’s disease

Date: April 22, 2024 at 5:54 am

Request ID: T2409 Leavens

Aim 1: Investigate misfolded SOD1 and tau seeding activities with Braak stage in sporadic Alzheimer’s disease

Aim 2: Determine SOD1 seeding activity in sporadic AD patient CSF

Aim 3:

Aim 4:


Investigator: Soumya Mukherjee, Katherine Schwetye

Project Title: Development of biofluid biomarker for cerebral amyloid angiopathy (CAA)

Date: March 20, 2024 at 12:08 pm

Request ID: T2408

Aim 1: Identify individuals with bio-fluid in the Knight ADRC Biobank database with confirmed postmortem neuropathological changes for cerebral amyloid angiopathy (CAA)

Aim 2: Compare the amyloid-beta concentrations in CAA patients with Alzheimer disease and controls in the biofluids (CSF and plasma) using IP-MS

Aim 3: Develop specific CSF and blood based biomarkers for CAA

Aim 4: